Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (IFF) (NYSE: IFF) generates a steady flow of news that reflects its role as a global leader in flavors, fragrances, food ingredients, health and biosciences. This news page aggregates company announcements, press releases and related coverage so readers can follow how IFF’s strategies, operations and governance evolve over time.
IFF’s news often highlights developments across its core segments—Taste, Health & Biosciences, Scent and Food Ingredients. Examples include updates on segment performance from quarterly earnings releases, commentary on market dynamics within these segments and information on productivity and margin initiatives. Investors and analysts can use these items to understand how the company’s segment-level trends contribute to overall performance.
Operational and technology-focused announcements are another key news category for IFF. Recent releases describe the implementation of the Colibri smart dosing robot at its Scent and Taste production plant in Chin Bee, Singapore, which is used to produce fragrance sample batches on demand, and the installation of a green hydrogen production facility at its Benicarló, Spain site to support sustainable fragrance ingredient manufacturing. News items also cover plans for new facilities, such as a scent creative center in Mumbai, India, designed to enhance fragrance innovation in that market.
Corporate governance, capital allocation and strategic partnerships feature prominently in IFF’s news flow. The company reports on board appointments, changes in committee assignments and amendments to its bylaws. It also announces dividends, share repurchase authorizations and collaborations, such as its strategic collaboration with BASF to develop next-generation enzyme technologies and biobased polymers. Bookmark this page to access a consolidated view of IFF’s latest publicly released information, from financial results to sustainability initiatives and board-level decisions.
International Flavors & Fragrances (NYSE: IFF) reported full-year 2025 net sales of $10.89B (reported -5%) and adjusted operating EBITDA of $2.086B. Reported loss before taxes was $(412)M and reported EPS was $(1.46); adjusted EPS ex amortization was $4.20.
The company launched a sale process for its Food Ingredients segment, generated $256M free cash flow, and provided 2026 guidance of $10.5B–$10.8B sales and $2.05B–$2.15B adjusted EBITDA.
Tastepoint by IFF (NYSE: IFF) identified ten flavor trends expected to influence North American retail and foodservice in 2026. The list spans citrus, nostalgic, global and sweet-spicy profiles including mandarin, cherry, sweet corn, French onion soup, cola, limoncello, sweet heat, pancake, tiramisu, and chai spice.
Flavors were selected from data-driven market analysis, menu tracking, social listening and consumer behavior to guide product development across confectionery, beverages, dairy, snacks, bakery and culinary categories.
IFF (NYSE:IFF) will release its fourth quarter and full year 2025 earnings after market close on Feb. 11, 2026. The management team will host a live webcast to discuss results and outlook on Feb. 12, 2026 at 9:00 a.m. ET, with slides available on the company investor site ir.iff.com. A replay of the webcast will be made available for later viewing.
IFF management will also present at the CAGNY conference on Feb. 19, 2026 at 1:00 p.m. ET. Investor relations contact: Michael Bender, 212.708.7263, Investor.Relations@iff.com.
Mativ Holdings (NYSE:MATV) appointed Deborah Borg to its Board of Directors, effective November 24, 2025. Borg will serve on Mativ’s Compensation Committee and Nominating & Governance Committee.
Borg is currently Executive Vice President and Chief People & Culture Officer at International Flavors & Fragrances (NYSE:IFF) and brings 25+ years of global leadership in compensation, benefits, succession planning, M&A and organizational change, with prior roles at General Motors, Dow Chemical and Bunge. Mativ leadership highlighted her experience guiding transformations and expected contributions to talent, strategy and culture as the company advances post‑merger objectives.
IFF (NYSE: IFF) installed a Colibri smart dosing robot at its Chin Bee production facility in Singapore on November 24, 2025, to speed fragrance sample production across Greater Asia. The system handles multiple ingredients simultaneously, runs four times faster than the previous setup and produces 200 sample batches in eight hours versus twenty-four hours before. The robot shortens formulation lead times from ideation to sample, increases automation and capacity, and complements IFF’s $30 million Singapore Innovation Center and other Colibri sites in Neuilly, France and Hilversum, Netherlands.
IFF (NYSE: IFF) opened a nature-based green hydrogen production facility at its Benicarló, Spain fragrance ingredients plant on November 6, 2025.
The site, in a 10-year renewable hydrogen agreement with Iberdrola, can produce 100 tons of green hydrogen annually, store it on-site with an integrated compressor, and supply hydrogenation for more than 50 key ingredients. IFF says the switch to green hydrogen will eliminate 2,000 tons of CO2e per year and supports its targets of -50% scope 1 & 2 and -30% scope 3 emissions by 2030 and net zero operations by 2040.
Summary not available.
IFF (NYSE: IFF) announced that its Board of Directors declared a regular quarterly cash dividend of $0.40 per share. The dividend is payable on January 9, 2026 to shareholders of record as of December 19, 2025.
The announcement reiterates IFF's ongoing capital return via a regular quarterly dividend and provides contact points for media and investor relations.
IFF (NYSE: IFF) announced the 2025 IFF Science Awards honoring Dr. Carles Lerín and Prof. Jan Maarten van Dijl for contributions to human health, nutrition, microbiome science and antimicrobial research.
Dr. Lerín is recognized for research on childhood and adolescent obesity, maternal and early-life nutrition, microbiome links to metabolic health and betaine’s role in growth. Prof. van Dijl is recognized for advances in molecular bacteriology, microbial protein secretion and novel antimicrobial strategies. The award continues the Danisco Foundation legacy and includes a $35,000 prize, with candidates chosen via a rigorous IFF nomination process.
IFF (NYSE: IFF) appointed Brett Icahn and Richard Mulligan, Ph.D. to its board of directors, effective Oct. 20, 2025. The appointments follow a previously disclosed cooperation agreement with Icahn Capital LP. Icahn replaces Vincent Intrieri and was named to the Board’s Audit Committee and Transaction Committee. Mulligan replaces Margarita Paláu-Hernández and was named to the Board’s Innovation Committee. Management highlighted Icahn’s investment experience and Mulligan’s scientific track record. Intrieri and Paláu-Hernández stepped down on Oct. 20, 2025.